We are live on ! Find out more
EP

Eversept Partners Portfolio holdings

AUM $1.93B Turnover 41.06%
1-Year Est. Return 160.8%
This Fund
S&P 500
This Quarter Est. Return
-3.92%
1 Year Est. Return
+160.8%
3 Year Est. Return
+321.09%
5 Year Est. Return
+420.29%
10 Year Est. Return
–
AUM
$1.18B
AUM Growth
-$14.4M
Cap. Flow
+$35M
Cap. Flow %
2.96%
Top 10 Hldgs %
62.21%
Holding
83
New
12
Increased
32
Reduced
19
Closed
14
Avg Time Held Equity + Options
1.3 years
Top 10 Avg Time Held Equity + Options
0.9 years
Top 20 Avg Time Held Equity + Options
1.1 years
Avg Time Held Equity only
1.5 years
Top 10 Avg Time Held Equity only
0.9 years
Top 20 Avg Time Held Equity only
1.2 years

Top Buys

Rank Stock Value
1
INSP icon
Inspire Medical Systems
INSP
+$27.9M
2
HQY icon
HealthEquity
HQY
+$22.9M
3
SWAV icon
Shockwave Medical, Inc. Common Stock
SWAV
+$15.2M
4
GSK icon
GSK
GSK
+$13.4M
5
TSVT icon
2seventy bio
TSVT
+$9.53M

Top Sells

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$29M
2
CTLT icon
CATALENT, INC.
CTLT
+$15.5M
3
ICLR icon
Icon
ICLR
+$12.8M
4
ABCM
Abcam PLC
ABCM
+$12.2M
5
AMRX icon
Amneal Pharmaceuticals
AMRX
+$9.77M

Sector Composition

Rank Sector Weight
1 Healthcare 76.1%
2 Miscellaneous 23.9%
3 Communication Services 0%
4 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
QQQ icon
1
PUT
Invesco QQQ Trust
QQQ
$482B
$143M 12.13%
400,000
+50,000
+14% +$18.5M
2023 Q1
2 quarters
GSK icon
2
GSK
GSK
$99.4B
$118M 10%
3,259,342
+378,330
+13% +$13.4M
2018 Q1
22 quarters
NTRA icon
3
Natera
NTRA
$56.5B
$110M 9.33%
2,492,636
+78,849
+3% +$4.02M
2022 Q2
5 quarters
SPY icon
4
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$814B
$103M 8.68%
240,000
+10,000
+4% +$4.45M
2023 Q1
2 quarters
TEVA icon
5
Teva Pharmaceutical Industries Limited
TEVA
$48.2B
$70.9M 6%
6,952,085
-715,959
-9% -$6.67M
2020 Q3
12 quarters
UTHR icon
6
United Therapeutics
UTHR
$23.1B
$60.5M 5.12%
267,903
+7,505
+3% +$1.73M
2020 Q2
13 quarters
INSP icon
7
Inspire Medical Systems
INSP
$2.03B
$38.3M 3.24%
193,018
+110,573
+134% +$27.9M
2023 Q2
1 quarter
SNDX icon
8
Syndax Pharmaceuticals
SNDX
$1.19B
$37.7M 3.19%
2,596,245
+406,513
+19% +$7.69M
2022 Q2
5 quarters
HCA icon
9
HCA Healthcare
HCA
$101B
$27.1M 2.29%
110,073
+29,348
+36% +$8.03M
2023 Q1
2 quarters
TECH icon
10
Bio-Techne
TECH
$11.4B
$26.3M 2.22%
385,889
+43,252
+13% +$3.42M
2022 Q4
3 quarters
DHR icon
11
Danaher
DHR
$161B
$25.7M 2.18%
117,068
+495
+0.4% +$110K
2018 Q3
20 quarters
HQY icon
12
HealthEquity
HQY
$7.61B
$24.7M 2.09%
+338,516
New +$22.9M
2023 Q3
0 quarters
HZNP
13
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$23.8M 2.01%
205,815
-269,495
-57% -$29M
2020 Q2
13 quarters
ILMN icon
14
Illumina
ILMN
$39.4B
$22.9M 1.94%
171,452
+43,927
+34% +$7.22M
2022 Q1
6 quarters
CYH icon
15
Community Health Systems
CYH
$426M
$20.7M 1.75%
7,146,088
-131,768
-2% -$488K
2020 Q4
11 quarters
VERA icon
16
Vera Therapeutics
VERA
$2B
$20.3M 1.72%
1,478,489
-262,462
-15% -$4.5M
2022 Q3
4 quarters
BCRX icon
17
BioCryst Pharmaceuticals
BCRX
$2.02B
$17.6M 1.49%
2,479,103
+106,990
+5% +$769K
2022 Q4
3 quarters
SWAV icon
18
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$16.8M 1.42%
84,462
+64,324
+319% +$15.2M
2023 Q1
2 quarters
CLDX icon
19
Celldex Therapeutics
CLDX
$2.24B
$16.2M 1.37%
588,143
-197,597
-25% -$6.19M
2021 Q4
7 quarters
CNC icon
20
Centene
CNC
$34.3B
$13.1M 1.11%
190,607
+37,874
+25% +$2.52M
2021 Q1
10 quarters
KRYS icon
21
Krystal Biotech
KRYS
$9.6B
$12.6M 1.07%
108,771
+2,306
+2% +$281K
2023 Q2
1 quarter
IONS icon
22
Ionis Pharmaceuticals
IONS
$7.23B
$11.5M 0.97%
252,446
+10,874
+5% +$449K
2021 Q2
9 quarters
AMRX icon
23
Amneal Pharmaceuticals
AMRX
$6.69B
$11.2M 0.94%
2,644,988
-2,620,263
-50% -$9.77M
2020 Q2
13 quarters
PCVX icon
24
Vaxcyte
PCVX
$9.99B
$9.71M 0.82%
190,430
-5,261
-3% -$260K
2022 Q4
3 quarters
TARO icon
25
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$9.63M 0.81%
255,323
+5,037
+2% +$189K
2019 Q4
15 quarters
1
2 3 4

Similar funds

SWM
Segment Wealth Management Houston, Texas $1.93B AUM 29.24% 1-Year Est. Return
RIA
Regal Investment Advisors Kentwood, Michigan $1.92B AUM 23.13% 1-Year Est. Return
SI
Standard Investments New York $1.93B AUM 6.23% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $1.92B AUM 45.54% 1-Year Est. Return
DCP
Distillate Capital Partners Chicago, Illinois $1.92B AUM 5.31% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.92B AUM 26.86% 1-Year Est. Return

Eversept Partners's Q3 2023 Portfolio in Review

As of Q3 2023, Eversept Partners held 83 positions worth $1.18B, down 1.2% from $1.2B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Eversept Partners's Q3 2023 filing shows 12 new, 32 increased, 19 reduced and 14 closed positions. Its largest new stake was HealthEquity: 338,516 shares worth $24.7M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $29M.

By sector, the portfolio is most concentrated in Healthcare at 76% of assets, down from 78% a quarter earlier, followed by Miscellaneous and Communication Services.

  • Eversept Partners's largest Q3 2023 buy was HealthEquity: 338,516 shares worth $24.7M.
  • Eversept Partners added most to Inspire Medical Systems in Q3 2023, an estimated $27.9M increase.
  • Eversept Partners's biggest Q3 2023 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $29M.
  • Eversept Partners fully exited CATALENT, INC. in Q3 2023, selling an estimated $15.5M.
  • Eversept Partners's ten largest holdings make up 62% of its $1.18B portfolio in Q3 2023.
  • Eversept Partners opened 12 new positions and closed 14 in Q3 2023.
  • Eversept Partners's portfolio value fell 1.2% quarter-over-quarter to $1.18B.

Based on Eversept Partners's 13F filing for Q3 2023, filed 14 Nov 2023.